What's Actually in a Klow Blend: Breaking Down the Individual Peptide Components

"Klow" blends are one of the most-searched multi-peptide reference formulations in the research-peptide space. Because the exact composition is supplier-dependent, understanding what is actually in a Klow blend — component by component — is the only way to make sense of the research literature attached to each piece.

This article breaks down the individual peptides that most commonly appear in a Klow-style research blend and links each one to its own mechanism-level research page.

The core trio

1. GHK-Cu — the copper-tripeptide component

GHK-Cu (Glycyl-L-Histidyl-L-Lysine complexed with copper II) is the naturally occurring tripeptide that most Klow-style blends are built around. In in-vitro research it has been characterised for its role in collagen and elastin gene upregulation, dermal-fibroblast signalling, and antioxidant activity through its copper-binding coordination chemistry.

Molecular signature: sequence Gly-His-Lys, formula C₁₄H₂₄N₆O₄Cu, molecular weight ~387.9 g/mol. The copper(II) ion is coordinated by four donor atoms — two nitrogen donors from the histidine imidazole ring, one from the lysine amine, and one oxygen from the deprotonated carboxylate — which is what makes the complex biologically active in dermal repair-pathway studies.

2. BPC-157 — the tissue-repair signalling component

BPC-157 (Body Protection Compound 157) is a 15-amino-acid partial sequence derived from a gastric protein. In in-vitro and animal models it has been studied for angiogenesis induction, upregulation of growth-hormone receptor expression, and effects on tendon, ligament and gut epithelial repair pathways. It is included in Klow-style blends as the deep-tissue repair-signalling component, complementing GHK-Cu's dermal-structural role.

3. TB-500 — the cellular-migration component

TB-500 is a synthetic fragment corresponding to a bioactive region of Thymosin Beta-4. Its documented research focus is actin-binding and cellular migration, which is why it is often paired with GHK-Cu (structural remodelling) and BPC-157 (angiogenic signalling) in multi-peptide blends.

Supplier-dependent additions

Beyond the core trio, Klow-style research blends frequently include one or more of the following:

• CJC-1295 (no-DAC) + Ipamorelin — a GHRH/GHRP pair used together in growth-hormone-axis research to trigger pulsatile GH release. See our full breakdown in CJC-1295 With DAC vs. Without DAC: The Half-Life Difference Explained.
• Selank — a heptapeptide studied for mood, anxiety, and cognitive-pathway research.
• Epitalon (Epithalon) — an ultra-short bioregulator peptide studied for telomere and pineal-gland pathway research.
• PEG-MGF — pegylated mechano-growth-factor variant with an extended half-life.

Any of these can appear on a supplier's Certificate of Analysis for a "peptide blend" product. Always match the label to the batch-specific COA.

Why the blend format exists at all

Rather than reconstituting five separate vials, a blended reference sample lets a lab study synergy across pathways in a single preparation — dermal + repair + regenerative signalling in one vial. The tradeoff is precision: fixed ratios mean you cannot titrate individual components independently.

Reading a Klow-blend COA

A legitimate blend COA should list each peptide by name, its per-vial mass, and the LC-MS confirmation for each component. Look for:

1. Third-party HPLC purity at 98% or higher, per component.
2. LC-MS identity confirmation matching the expected mass of each peptide.
3. Endotoxin below 1.0 EU/mg.
4. Salt form disclosed (acetate is preferred over TFA salts).

If a supplier ships a "blend" without a per-component breakdown, treat it as an unknown mixture — not a research-grade reference material.

Research use only

Every compound described here is offered strictly for in-vitro laboratory research and educational study. None of the descriptions above constitute therapeutic, dietary, or clinical guidance.

For laboratory and research use only. Not for human consumption.